Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 2/2004

01-02-2004 | Original Article

P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells

Authors: Anna Bielak-Żmijewska, Katarzyna Piwocka, Adriana Magalska, Ewa Sikora

Published in: Cancer Chemotherapy and Pharmacology | Issue 2/2004

Login to get access

Abstract

Purpose

One of the mechanisms responsible for the multidrug resistance (MDR) phenotype of cancer cells is overexpression of so-called ATP-dependent drug efflux proteins: the 170-kDa P-glycoprotein (P-gp) encoded by the MDR1 gene and the 190-kDa multidrug resistance-associated protein 1 encoded by the MRP1 gene. The purpose of the present study was to verify the hypothesis postulating that P-gp expression, apart from enabling drug efflux, confers on the cells resistance to apoptosis by inhibiting caspase-8 and caspase-3.

Materials and methods

Human HL-60 cells, either drug-sensitive or with the MDR phenotype caused by overexpression of P-gp (HL-60/Vinc) or MRP1 (HL-60/Adr), were treated with the natural dye curcumin at 50 μM or with UVC to induce apoptosis. Symptoms of cell death were assessed by morphological observation after Hoechst staining, DNA fragmentation was measured by flow cytometry and the TUNEL method, and caspase-8 and caspase-3 activation and cytochrome c release from mitochondria were measured by Western blotting.

Results

Curcumin induced cell death in HL-60 cells, both sensitive and with the MDR phenotype, which could be classified as caspase-3-dependent apoptosis, together with cytochrome c release, activation of caspase-3 and oligonucleosomal DNA fragmentation. No active caspase-8 was detected. Also UVC caused caspase-3 activation in both the sensitive and the MDR HL-60 cells.

Conclusions

Our findings show that there was no correlation between P-gp expression and resistance to caspase-3-dependent apoptosis induced by curcumin and UVC, at least in HL-60 cells. However, we cannot exclude the possibility of parallel P-gp expression and caspase-3 inhibition in some other cell lines, as cancer cells can acquire many different apoptosis-resistance mechanisms.
Literature
1.
go back to reference Bielak-Żmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E (2000) Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38:131PubMed Bielak-Żmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E (2000) Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38:131PubMed
2.
go back to reference Borner C, Monney L (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 6:497CrossRefPubMed Borner C, Monney L (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 6:497CrossRefPubMed
3.
go back to reference Bush JA, Cheung KJ Jr, Li G (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271:305CrossRefPubMed Bush JA, Cheung KJ Jr, Li G (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271:305CrossRefPubMed
4.
go back to reference Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L (2001) Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein. Leukemia 15:1377CrossRefPubMed Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L (2001) Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein. Leukemia 15:1377CrossRefPubMed
5.
go back to reference Cullen K, Davey R, Davey M (2001) The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death. Cytometry 43:189CrossRefPubMed Cullen K, Davey R, Davey M (2001) The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death. Cytometry 43:189CrossRefPubMed
6.
go back to reference Huang P, Oliff A (2001) Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol 11:343CrossRefPubMed Huang P, Oliff A (2001) Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol 11:343CrossRefPubMed
7.
go back to reference Johnstone RW, Cretney E, Smyth MJ (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93:1075PubMed Johnstone RW, Cretney E, Smyth MJ (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93:1075PubMed
8.
go back to reference Johnstone RW, Ruefli AA, Tainton KM, Smyth MJ (2000) A role for P-glycoprotein in regulating cell death. Leuk Lymphoma 38:1PubMed Johnstone RW, Ruefli AA, Tainton KM, Smyth MJ (2000) A role for P-glycoprotein in regulating cell death. Leuk Lymphoma 38:1PubMed
9.
go back to reference Johnstone RW, Tainton KM, Ruefli AA, Froelich CJ, Cerruti L, Jane SM, Smyth MJ (2001) P-glycoprotein does not protect cells against cytolysis induced by pore- forming proteins. J Biol Chem 276:16667CrossRefPubMed Johnstone RW, Tainton KM, Ruefli AA, Froelich CJ, Cerruti L, Jane SM, Smyth MJ (2001) P-glycoprotein does not protect cells against cytolysis induced by pore- forming proteins. J Biol Chem 276:16667CrossRefPubMed
10.
go back to reference Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T (2002) Current status of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chem Pharmacol 50:343CrossRef Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T (2002) Current status of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chem Pharmacol 50:343CrossRef
11.
go back to reference Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S (1995) Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123. Eur J Cancer 31A:1682PubMed Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S (1995) Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123. Eur J Cancer 31A:1682PubMed
13.
go back to reference Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513PubMed Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513PubMed
14.
go back to reference Lehne G (2000) P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets 1:85PubMed Lehne G (2000) P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets 1:85PubMed
15.
go back to reference McGrath T, Center MS (1987) Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem Biophys Res Commun 145:1171PubMed McGrath T, Center MS (1987) Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem Biophys Res Commun 145:1171PubMed
16.
go back to reference McGrath T, Center MS (1988) Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. Cancer Res 48:3959PubMed McGrath T, Center MS (1988) Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. Cancer Res 48:3959PubMed
17.
go back to reference McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL, Center MS (1989) Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 38:3611PubMed McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL, Center MS (1989) Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 38:3611PubMed
18.
go back to reference Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D’Alessandro N (2002) Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 180:91CrossRefPubMed Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D’Alessandro N (2002) Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 180:91CrossRefPubMed
19.
go back to reference Ogretmen B, Safa AR (1999) Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry 38:2189CrossRefPubMed Ogretmen B, Safa AR (1999) Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry 38:2189CrossRefPubMed
20.
go back to reference Piwocka K, Zablocki K, Wieckowski MR, Skierski J, Feiga I, Szopa J, Drela N, Wojtczak L, Sikora E (1999) A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 249:299CrossRefPubMed Piwocka K, Zablocki K, Wieckowski MR, Skierski J, Feiga I, Szopa J, Drela N, Wojtczak L, Sikora E (1999) A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 249:299CrossRefPubMed
21.
go back to reference Piwocka K, Bielak-Żmijewska A, Sikora E (2002) Curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells. Ann N Y Acad Sci 973:250PubMed Piwocka K, Bielak-Żmijewska A, Sikora E (2002) Curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells. Ann N Y Acad Sci 973:250PubMed
22.
23.
go back to reference Ruefli AA, Smyth MJ, Johnstone RW (2000) HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95:2378PubMed Ruefli AA, Smyth MJ, Johnstone RW (2000) HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95:2378PubMed
24.
go back to reference Ruefli AA, Bernhard D, Tainton KM, Kofler R. Smyth M, Johnstone RW (2002) Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells. Int J Cancer 99:292CrossRefPubMed Ruefli AA, Bernhard D, Tainton KM, Kofler R. Smyth M, Johnstone RW (2002) Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells. Int J Cancer 99:292CrossRefPubMed
25.
go back to reference Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E (1997) Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54:899CrossRefPubMed Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E (1997) Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54:899CrossRefPubMed
26.
go back to reference Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, Park JW, Kwon TK (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199CrossRefPubMed Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, Park JW, Kwon TK (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199CrossRefPubMed
Metadata
Title
P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells
Authors
Anna Bielak-Żmijewska
Katarzyna Piwocka
Adriana Magalska
Ewa Sikora
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 2/2004
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-003-0705-x

Other articles of this Issue 2/2004

Cancer Chemotherapy and Pharmacology 2/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine